Product Ref: MBPRO09 Category: P
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
Category | POM-V |
Temperature | Refrigerated |
MA/VM/EU No: | 04491/5047 |
Species |
|
VMD Link | https://www.vmd.defra.gov.uk/ProductInformationDatabase/product/A006565 |
NOAH Link | |
Dosage | Amounts to be administered and administration route For intramuscular use. For the administration of the vaccine, use sterile and antiseptic-free and/or disinfectant-free material. Shake the vaccine gently before use. 1st scheme – vaccination against equine influenza Administer one dose (1 ml of ProteqFlu), by intramuscular injection, preferably in the neck region, according to the following schedule: -Primary vaccination course: First injection from 5-6 months of age, second injection 4-6 weeks later. -Revaccination: 5 months after primary vaccination course followed by annual booster injections. In case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 5-6 months of age and 4-6 weeks later followed by revaccination). 2nd scheme – vaccination against equine influenza and tetanus Administer one dose (1 ml), by intramuscular injection, preferably in the neck region, according to the following schedule: Primary vaccination course with ProteqFlu-Te: First injection from 5-6 months of age, second injection 4-6 weeks later. Revaccination: 5 months after primary vaccination course with ProteqFlu-Te. Followed by: - against tetanus: injection of 1 dose at an interval of maximum 2 years with ProteqFlu-Te. - against equine influenza: injection of 1 dose every year, alternatively with ProteqFlu or ProteqFlu-Te, respecting an interval of maximum 2 years for the tetanus component. In case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu-Te can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 5-6 months of age and 4-6 weeks later followed by revaccination). Overdose Following the administration of overdoses of vaccine, no side-effects other than those described under Adverse reactions have been observed. |
Withdrawals | Withdrawal period Zero days. |